These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5298445)

  • 41. [Application of the proteinase inhibitor trasylol in surgical disorders and surgical interventions].
    Boettger G
    Hospital (Rio J); 1967 Nov; 72(5):1393-404. PubMed ID: 4242959
    [No Abstract]   [Full Text] [Related]  

  • 42. Reply to invited letter concerning: Aprotinin (J Thorac Cardiovasc Surg 1991; 101:1103-4).
    Blauhut B; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):386-7. PubMed ID: 1370972
    [No Abstract]   [Full Text] [Related]  

  • 43. [TEG studies on the effect of trasylol on blood clotting and on the survival of animals in experimental shock].
    Pelasa J
    Pol Tyg Lek; 1969 Jan; 24(2):49-51. PubMed ID: 5305939
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel surface modification using tissue factor reconstituted in phospholipid vesicles for the activation of blood coagulation.
    Svedhem S; Wikström A; Deinum J; Kasemo B; Hansson K
    J Biomater Sci Polym Ed; 2009; 20(1):133-40. PubMed ID: 19105905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
    Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI.
    Nielsen VG
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):168-72. PubMed ID: 16430537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL; Howard C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Realease of anticoagulants and fibrinolysis activator by a nervous mechanism following renal perfusion with surface factor and thrombin.
    Neri Serneri GG; Masotti G; Paoletti P; Silvestrini E; Donnini L
    Rass Neurol Veg; 1968; 22(5):445-68. PubMed ID: 5714088
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the modification of postoperative blood circulation and coagulation changes with the proteinase inhibitor trasylol].
    Haberland GL; Matis P; Pauschinger P; Thies HA; Vinazzer H
    Med Welt; 1969 May; 22():1270-5. PubMed ID: 5306519
    [No Abstract]   [Full Text] [Related]  

  • 52. [Biological effects of thrombin].
    Malezhik LP; Al'fonsov VV; Kuznik BI
    Fiziol Zh SSSR Im I M Sechenova; 1984 Jan; 70(1):16-22. PubMed ID: 6698246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Review. Endotoxins and blood coagulation].
    Kase F; Rennerová J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):1-15. PubMed ID: 6164602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Reciprocal effects between the promoting and inhibiting substances of the blood coagulation].
    HECHT E
    Experientia; 1954 Oct; 10(10):428-9. PubMed ID: 13220569
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of different forms of aprotinin during cardiopulmonary bypass.
    De Bakker A; De Hert S; Vlaeminck R; Delrue G; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(2):45-51. PubMed ID: 7694437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on plasma factor involved in 5-hydroxytryptamine release from blood platelets by bacterial endotoxin. 3. Mechanism of action of 5-hydroxytryptamine releasing factor.
    Nomura Y; Okada T; Takagi H
    Jpn J Pharmacol; 1972 Feb; 22(1):79-87. PubMed ID: 4537627
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in the blood coagulation in dogs following intravenous injection of thromboplastin].
    Rusakova GP
    Patol Fiziol Eksp Ter; 1965; 9(5):82-4. PubMed ID: 5877806
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage.
    Furmaniak-Kazmierczak E; Cooke TD; Manuel R; Scudamore A; Hoogendorn H; Giles AR; Nesheim M
    J Clin Invest; 1994 Aug; 94(2):472-80. PubMed ID: 8040300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood coagulation and acute iron toxicity. Reversible iron-induced inactivation of serine proteases in vitro.
    Rosenmund A; Haeberli A; Straub PW
    J Lab Clin Med; 1984 Apr; 103(4):524-33. PubMed ID: 6421970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procoagulant action of aprotinin.
    Alston TA
    Anesth Analg; 1996 Jun; 82(6):1305-6. PubMed ID: 8638818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.